by Jordana Choucair | Feb 2, 2022 | Opioid/Substance Use Disorders
A group of 574 Native American tribes reached a tentative $590 million settlement with Johnson & Johnson and the country’s three largest drug distributors — McKesson Corp., Cardinal Health Inc., and AmerisourceBergen Corp. — over their role in the opioid...
by Jordana Choucair | Feb 1, 2022 | Opioid/Substance Use Disorders
Adolescents and young adults lost an estimated 1.2 million years of life due to unintentional drug overdoses over between 2015 and 2019, according to a research letter published in JAMA. About 3,300 adolescents ages 10–19 years old died of an unintentional drug...
by Jordana Choucair | Jan 26, 2022 | Opioid/Substance Use Disorders
Rhode Island Attorney General Peter Neronha announced the state reached a settlement with an opioid manufacturer and opioid distributors. The settlement includes $21.1 million from Johnson & Johnson and an additional $90.8 million in total from AmerisourceBergen,...
by Jordana Choucair | Jan 14, 2022 | Opioid/Substance Use Disorders
An article in Treatment Magazine describes the need for value-based substance use disorder treatment, highlighting insights from Greg Williams, Third Horizon Strategies Managing Partner and Manager of the Alliance for Addiction Payment Reform (Alliance). The article...
by Jordana Choucair | Jan 12, 2022 | Opioid/Substance Use Disorders
A new study published in JAMA Network Open found that the annual opioid overdose death rate per 100,000 persons for adults aged 55 and older increased substantially since 2019. Furthermore, rates varied substantially by sex and by race and ethnicity over time....
by Jordana Choucair | Dec 30, 2021 | Opioid/Substance Use Disorders
U.S. Bankruptcy Judge Robert Drain has extended temporary protections against opioid-related litigation for the Sackler family members who own Purdue Pharma until February 1. In September, Drain had approved Purdue’s reorganization plan and underlying settlement,...
Recent Comments